Navigation Links
Chemists Discover Cation Considered Too Unstable To Exist ,,

Organic chemistry textbooks will need to be revised to recognize a chemical species that chemists have discovered. The species - pentamethylcyclopentadienyl cation (a positively charged ion) - was thought not to exist for long because theory said it was unstable. //

"I’ve said this molecule is unstable and doesn’t exist dozens of times in organic chemistry class, but, as it turns out, the molecule had different ideas," said Joseph B. Lambert, Clare Hamilton Hall Professor of Chemistry at Northwestern. He and graduate student Lijun Lin discovered that the cation is stable in the solid state for weeks at room temperature and in solution.

The cyclopentadienyl cation is a common textbook example of an antiaromatic molecule, a molecule so electronically unstable and, therefore, extremely reactive that it should not exist for any length of time. Lambert believes the cation now should be described as nonaromatic.

Lambert and Lin discovered the molecule when trying to figure out how to make stable organic cations in the laboratory. When Lin came to Lambert with the crystal structure of a molecule other than the one expected, Lambert quickly recognized the structure as an example of the elusive cyclopentadienyl cation of textbook fame. Lambert and Lin currently are studying the chemistry of the pentamethylcyclopentadienyl cation by carrying out reactions with the cation to learn more about its properties
'"/>




Page: 1

Related medicine news :

1. Chemists prepare for face-off with manufacturers
2. Jharkhand Chemists to Boycott Viagra
3. Stricter Norms for Chemists in Punjab to Curb Addiction
4. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
5. Discovery of bone gene
6. Discovering cholesterol-absorbing genes
7. Origin Of SARS Virus Discovered
8. Another Cause of Thyroid Cancer Discovered
9. Details Of Heart Failure Discovered
10. New Discovery May Help Treat Infertility
11. New Discovery to Increase Survival of Breast cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... ... ... A new collaboration will give more researchers access to the largest and ... leader SAS will provide researchers worldwide with data management and analytics tools to explore ... , The DCRI and SAS share the goal of greater transparency and openness in ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star ... created to assist the people of their local community. The agency pledges to ... community leaders. Their hope is to bring awareness to important local causes with ...
(Date:5/4/2016)... Dallas, Texas (PRWEB) , ... May 04, 2016 , ... ... cancer awareness in people across the United States. Dermatologist Dr. Ellen Turner is encouraging ... heed dermatology experts’ advice and focus on skin safety and health now and in ...
(Date:5/4/2016)... CA (PRWEB) , ... May 04, 2016 , ... Dr. ... offering wisdom tooth removal surgery at their office. Wisdom tooth removal, a common dental ... not always problematic, they often are improperly erupted, resulting in risks of complications. By ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nordic Naturals ... cellular and metabolic health. This synergistic combination of omega-3 fatty acids and potent ... 150 mg of reduced glutathione and 200 mg of N-Acetylcysteine (NAC). , ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... -- According to market research "Global Magnetic ... Demand Forecast to 2022 - Industry Insights by Architecture ... High Field, Low to Mid Field, and Ultra High ... Vascular, Breast, Pelvic and Abdomen, Cardiac, and Other)" P&S ... was valued at $5,351.7 million in 2015, and it ...
(Date:5/3/2016)... May 3, 2016 ... dass sie einen entscheidenden Meilenstein durch diese ... Aufruf zum Handeln, um Patientenresultate  bei Verdauungs- ... zu Fortschritten im Verständnis der Hepatischen Enzephalopathie ... Bewusstsein für Hepatische Enzephalopathie in der Öffentlichkeit ...
(Date:5/2/2016)...  Celsion Corporation (NASDAQ: CLSN ), an ... the first cohort of patients in its Phase ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... the first three patients dosed, GEN-1 plus standard ...
Breaking Medicine Technology: